NCT00004276View on ClinicalTrials.gov

Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections

PHASE2CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

September 30, 1990

Study Completion Date

June 30, 1999

Conditions

HIV InfectionsMycobacterium InfectionsTuberculosis

Interventions

DRUG

thalidomide

All Listed Sponsors

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Rockefeller University

OTHER

lead

National Center for Research Resources (NCRR)

NIH